FDA Inspection 1165884 — Bristol Myers Squibb

Bristol Myers Squibb — FEI 1000527006

The FDA completed an inspection of Bristol Myers Squibb on Feb 2, 2022 in Lawrenceville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 2, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lawrenceville, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.